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Abstract
Background: The application of advanced 3T MRI imaging techniques to study recovery after subarachnoid
hemorrhage (SAH) is complicated by the presence of image artifacts produced by implanted aneurysm clips. To
characterize the effect of these artifacts on image quality, we sought to: 1) quantify extent of image artifact in SAH
patients with implanted aneurysm clips across a range of MR sequences typically used in studies of volumetry,
blood oxygen level dependent signal change (BOLD-fMRI), and diffusion-weighted imaging (DW-MRI) and 2) to
explore the ability to reconstruct white matter pathways in these patients.
Methods: T1- and T2-weighted structural, BOLD-fMRI, and DW-MRI scans were acquired at 3T in two patients with
titanium alloy clips in ACOM and left ACA respectively. Intensity-based planimetric contouring was performed on
aligned image volumes to define each artifact. Artifact volumes were quantified by artifact/clip length and artifact/
brain volume ratios and analyzed by two-way (scan-by-rater) ANOVAs. Tractography pathways were reconstructed
from DW-MRI at varying distances from the artifacts using deterministic methods.
Results: Artifact volume varied by MR sequence for length (p = 0.007) and volume (p < 0.001) ratios: it was
smallest for structural images, larger for DW-MRI acquisitions, and largest on fMRI images. Inter-rater reliability was
high (r = 0.9626, p < 0.0001), and reconstruction of white matter connectivity characteristics increased with
distance from the artifact border. In both patients, reconstructed white matter pathways of the uncinate fasciculus
and inferior fronto-occipital fasciculus were clearly visible within 2 mm of the artifact border.
Conclusions: Advanced 3T MR can successfully image brain tissue around implanted titanium aneurysm clips at
different spatial ranges depending on sequence type. White matter pathways near clip artifacts can be
reconstructed and visualized. These findings provide a reference for designing functional and structural
neuroimaging studies of recovery in aSAH patients after clip placement.
Keywords: artifact, BOLD-fMRI, diffusion-weighted imaging, inferior fronto-occipital fasciculus, intracranial aneurysm
clip, magnetic resonance imaging, subarachnoid hemorrhage, titanium alloy, uncinate fasciculus
Background
Recent advances in aneurysmal subarachnoid hemor-
rhage (aSAH) management have led to consistent
improvement in survival, with case fatality rates decreas-
ing 0.9% every year without a rebound increase in the
proportion of survivors with severe disabilities [1]. Most
published data on aSAH use the Glasgow Outcome Scale
(GOS) and modified Rankin Scale (mRS) that place
patients with mild disabilities in a ‘Good Recovery’ cate-
gory. However, even patients who make a good recovery
based on these outcome scales suffer from varying
degrees of cognitive deficits, including most prominently
problems with memory [2,3]. These deficits impair day-
to-day functioning, impact workplace productivity, and
affect social interactions often during the most produc-
tive years of patients’ l i v e s .W h i l eag r o w i n gb o d yo f
literature documents these cognitive deficits in aSAH
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tests [2-6], far fewer studies have attempted to relate cog-
nitive deficits to specific neurobiological changes.
The acquisition of advanced neuroimaging sequences
and application of recently developed analysis techniques
promises to shed more light on the relationship between
brain changes following aSAH and specific cognitive defi-
cits. Such techniques include 1) high spatial resolution
(1 mm
3) structural MRI volumes to measure cortical
thickness and gray/white matter density using voxel
based morphometric techniques [7,8], 2) high temporal
resolution (1-2 sec) blood oxygen level dependent func-
tional MRI [9] to measure rest-state [10,11] and task-
evoked hemodynamic changes [12], and 3) diffusion-
weighted MRI (DW-MRI) to measure white matter integ-
rity and connectivity [13-16]. A recent set of voxel-based
morphometric studies employed structural MRI acquired
at 1.5 tesla and demonstrated gray matter atrophy in
multiple brain areas following aSAH that, in some cases,
correlate with neuropsychological deficits [17-20]. How-
ever, many more systematic imaging studies will be
required to unravel the complex set of brain changes
caused by accumulation of subarachnoid blood, lesions
induced by intraparenchymal hemotomas frequently seen
with aneurysm rupture (Fisher Grade 4 [21]), vasospasm-
induced ischemic damage, and surgical retraction/manip-
ulation of local tissue. The widespread availability of
high-field (3 tesla and greater) in clinical and research
MRI centers will reduce the time to acquire advanced
sequences and provide increased signal-to-noise ratios
compared to lower field scanners [22-24].
Treatment of many aSAH patients involves the surgical
placement of non-ferromagnetic (e.g., titanium alloy)
intracranial aneurysm clips [25,26]. These patients are
routinely scanned clinically at 1.5 tesla field strength
[27,28] if the implanted clips are confirmed by written
record to be made from titanium or other non-metallic
materials that have been tested [29-37]. Clips made with
ferromagnetic materials are unsafe even at low field
strengths [38,39] and if operative records indicate these
are implanted then patients cannot be scanned. Recent
studies have assessed various characteristic (e.g., torque
and translational attraction, MRI-related heating, and
artifacts) in high-field strength MR environments of clips
made from a range of non-ferromagnetic materials,
including titanium alloy, at high field strengths from 3 up
to 8 tesla [40-44]. While it may be routine clinical prac-
tice to obtain MRI scans in patients with these clips, the
implants produce a noticeable artifact in the images.
These artifacts have never been quantitatively described
in vivo at high field (> 1.5 tesla) in aSAH patients,
although basic characteristics of artifacts have been
reported for imaging obtained with clips in phantoms at
1.5 tesla and higher [29,34,45,46].
Given previous studies of MRI artifacts from aneurysm
clip implants in humans conducted at low field strength
and studies at both low and high field strengths con-
ducted with phantoms, we expected at the outset of this
study to find that artifact size depends on the type of
pulse sequence. The novelty of our study is that it is con-
ducted at 3T in vivo with patients who have a history of
SAH, and that artifact size is quantified across a range of
acquisitions using parameters that are typically found in
advanced research MRI studies of cognitive function.
The major motivation to characterizing the MR artifact
in vivo rather than in phantoms is that the results can be
interpreted from a clinically-relevant perspective in order
to give neurosurgeons, neuroradiologists and researchers
alike an idea of how much signal loss varies across these
acquisitions before they embark on large-sample imaging
studies of neurocognitive recovery after SAH. A descrip-
tion of artifact characteristics obtained in vivo across a
range of advanced image acquisition sequences is neces-
sary in order to understand the extent of signal integrity
around the aneurysm clip. Only after the boundary of sig-
nal loss around the clip is quantified can the signal
changes arising from damage due to the hemorrhage,
normal signal change from healthy brain tissue, and con-
nectional neuroanatomy near implanted clips, like that
made possible by DW-MRI tractography, be adequately
summarized.
Objectives
Image artifact due to the presence of titanium alloy
aneurysm clips is generally acknowledged to be minimal.
Yet no in vivo data is available from aSAH patients to
guide clinicians and researchers in estimating the extent
of aneurysm clip artifact in images reconstructed from
advanced high-field (> 1.5 tesla) MR sequences. In this
paper, we test the null hypothesis that the resulting arti-
fact from implanted titanium alloy clips is spatially simi-
lar across high-resolution T1- and T2-weighted
structural, T2* echo-planar BOLD-fMRI, and DW-MRI
images when clinical characteristics related to the extent
of aSAH and clip characteristics are similar. We also
explore the ability to reconstruct temporal and frontal
lobe white matter fiber pathways reconstructed using
deterministic tractography methods from the DW-MRI
acquisitions, and quantify pathway density at different
distances from the artifact border.
Methods
Patients
Two patients with a history of SAH who were treated by
placement of titanium alloy aneurysm clips were imaged
after giving informed verbal and written consent for
enrollment in the study. Patients gave informed consent
for their brain images to be published. This research
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tion of Human Subjects of The University of Texas
Health Science Center at Houston (HSC-MS-09-0497).
The two patients were similar in terms of the degree
and distribution of SAH, its intraparenchymal compo-
nent, the degree and severity of vasospasm [47], the sur-
gical approach taken, and characteristics of implanted
clips, including composition, in-vivo clip orientation,
and dimensions (for details of each, see Table 1). We
did not study patients with clips made from Phynox,
MP35N, and Elgiloy, as these clips are not routinely
implanted at our institution, nor did we study patients
with curved, right-angle or other more complicated clip
configurations.
Image Acquisition
The following brain scans were obtained using a 3T Phi-
lips Intera scanner (Philips Medical Systems, Bothell
WA; 8-channel SENSE acquisition): (1) T2-weighted
turbo-spin echo 3D volume acquisition (repetition [TR]/
echo time [TE] = 2500/367 ms; ETL 120, pixel band-
width 380, FA = 90 degrees, matrix size = 256 × 256;
field of view [FOV] = 240 mm, 186 0.94 mm thick con-
tiguous, sagittal slices), (2) high-resolution 3D T1-
weighted magnetization-prepared rapid acquisition
turbo field echo sequence (TR/TE = 8.4/3.9ms; FA = 8
deg; matrix size = 256 × 256; FOV = 240 mm; slice
thickness = 1.0 mm thick sagittal slices), (3) a set of dif-
fusion-weighted image volumes (32-directions high
angular resolution) using the gradient overplus option
with one B0 (non-diffusion weighted) image volume
acquired before the acquisition of one repetition of the
diffusion-weighted scans (TR/TE = 8500/67 ms; FA =
90 deg; matrix size 128 × 128; FOV = 224 mm; 2 mm
thick axial slices, b-value of 800 s/mm
2), (4) a set of
functional images obtained with a gradient-recalled
echo-planar imaging (EPI) sequence sensitive to the
blood-oxygen level dependent (BOLD) signal (TR/TE =
2000/30 ms; FA = 90 deg; matrix size = 80 × 80; FOV =
220 mm; 3 mm thick axial slices, 150 dynamics). These
Table 1 Patient Demographics and Aneurysm Clip Characteristics
Patient A Patient B
Patient Demographics
Age 62 36
Sex FF
Hunt and Hess Grade 34
Fisher’s Grade 44
SAH Distribution Bilateral, L > R Bilateral, L > R
Aneurysm location ACOM Left ACA
Intraparenchymal Component Left Frontal Left Frontal
Focal Neurological Deficits Yes Yes
Vasospasm Clinically significant requiring endovascular
intervention
Clinically significant requiring endovascular
intervention
Surgery
Approach Left Pterional Left Pterional
Operative findings Hemosiderin deposition on brain surface Significant subarachnoid blood
Time between SAH and Surgery 11 months 9 days
Time between Surgery and 3T MR
Scan
5 months 15 months
Clip Specifications
Manufacturer Aesculap Yasargil FT720T (Aesculap, Germany) Aesculap Yasargil FT760T
(Aesculap, Germany)
Composition Titanium Alloy
Ti6A14V ISO 5823-3
Titanium Alloy
Ti6A14V ISO 5823-3
Size 7 mm (mini) 11 mm (Standard)
Weight 0.08 g 0.19 g
Width 0.95 mm 1.35 mm
Shape Straight Straight
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here because they are commonly applied in structural
and functional studies of cognition in both healthy con-
trols [48] and different patient groups [49,50]. Identical
MR parameters were used to scan both patients; no
attempt was made to adjust these parameters on an
individual patient basis to minimize artifact extent.
Image Analysis
Image visualization and artifact quantification was per-
formed using the AFNI package [51]. Two raters with fel-
lowship training in neuroimage analysis and who were
blind to each other’s results performed intensity-based
planimetric contouring to define each artifact. The T2,
EPI and DW image volumes were aligned to the T1
volume using the 3dAlineate alignment algorithm with a
mutual information cost function in AFNI. Each rater
created 3D binary masks on the aligned volumes that
encompassed the entire spatial extent of the artifact on
each patient’sT 1 ,T 2 ,m e a nE P I ,a n dt h eB 0d i f f u s i o n -
weighted scans. The artifact was clearly visible in each of
the four different acquisitions, and verified numerically
to consist of a low intensity (i.e., black) region wherein
the highest intensity image value at the center of the arti-
fact was verified across all patients and all scans to never
exceeded 10% of the global image maximum. The consis-
tent behavior of the artifact intensity allowed for the
choice of an intensity-based threshold to be automatically
chosen during 3D contouring of the artifact border. After
the artifact was delineated, the long-axis and total volume
for each of these binary masks was then measured by
summing mask voxel volumes. Most importantly, for
comparison across patients and MR sequences, artifact
volume was expressed as a percentage of whole brain
volume, defined as the total gray and white matter of the
brain as computed in Freesurfer v4.5 [52,53].
To determine whether the clip artifact differed signifi-
cantly as a function of scan sequence and rater, two 2-
w a ya n a l y s e so fv a r i a n c ew e r ec o n d u c t e du s i n gS P S S
(v.13). In the first ANVOA, the dependent variable was
the artifact length/clip length ratio, and the two fixed fac-
tors were rater (2-levels: rater 1 & 2) and scan sequence
(4-levels: T1, T2, EPI, and DW). In the second ANOVA,
the dependent variable was the artifact volume/brain
volume ratio, and the two fixed factors were rater (2-
levels: rater 1 & 2) and scan sequence (4-levels: T1, T2,
EPI, and DW). These ANOVAs had 3 and 15 numerator
and denominator degrees of freedom, allowing for a
priori p < 0.05 statistical threshold for the fixed effects of
rater and scan sequence. Due to the few patients studied,
no statistical interpretation about the random effect of
patient was possible.
To quantify how the number of white matter tracto-
graphy pathways varied as a function of distance from
the artifact, diffusion tractography pathways were com-
puted from the set of aligned diffusion-weighted images
according to previously described methods [54,55].
Then, the artifact mask delineated on the diffusion-
weighted scan was morphologically dilated in three
dimensions by increments of the native-space DW voxel
resolution (2 mm), and all pathways intersecting with
the dilated mask were saved and visualized in DTI
Query [56].
Results
The means and standard deviations of the two raters’
measurements of each patient’s artifact are listed by
imaging sequence in Table 2.
For both patients, the artifact appeared smallest on
T2-weighted structural volume (0.21% to 0.45% of
whole brain volume, artifact/clip length ratio of 2.82 to
2.89) and the largest on the EPI functional image (3.21%
to 3.94% of whole brain volume, artifact/clip length
ratio of 4.75 to 6.55).
Significant main effects of scan type were found by the
ANOVA of artifact length/clip length ratio (F(3,15) =
8.51, p = 0.007), and the ANOVA of artifact volume/
brain volume ratio (F(3,15) = 22.25, p < 0.001) supporting
the hypothesis the artifact size varies among the differ-
ent MR acquisition sequences. Further evidence was
found by computing post-hoc tests for significant (p <
0.05) differences among the means (Bonferroni cor-
rected for multiple comparisons). These showed differ-
ences between the structural (T1 and T2) and EPI
sequences for the artifact length/clip length ratios, and
between the structural (T1 and T2) and EPI and DW
sequences for the artifact volume/brain volume ratios.
Differences between the EPI and DW artifact volume/
brain volume ratios trended toward but failed to reach
significance (p = 0.11).
Inter-rater reliability for all measurements (artifact
volume, artifact as percentage of brain volume, and arti-
fact length) was very high (r = 0.9626, p < 0.0001)
demonstrating objective differentiation between raters of
the artifact size as a function of MR sequence. In gen-
eral, inter-rater variability in estimation of artifact length
was low (Range: 0.21-1.80 mm for T2, 4.41-4.72 mm for
EPI) and artifact volume was relatively high (Range:
101-185 mm
3 for T2, 2728-4767 mm
3 for EPI). There
were no significant main effects of rater found in either
the ANOVA of artifact length/clip length ratio or the
ANOVA of artifact volume/brain volume ratio, showing
that estimates of artifact size were consistent and did
not differ systematically by individual rater.
Artifact size differences are easily visualized by com-
paring an image plane across different MR sequences
taken through the center of the artifact (Figure 1). On
all sequences in both patients, the maximum length
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than the actual clip length, ranging from 2.82 times the
length of the clip for the T2 structural sequence to 6.5
times the length of the clip for the EPI sequence.
Computed whole-brain volumes were 229,705 and
242,419 mm
3 for patient’sAa n dBr e s p e c t i v e l y .T h e s e
values are in line with an average of whole brain
volumes, 235,821 (SD 22,571), computed from a group
of similar aged controls (N = 7, 3F, 1LH, 54.0 years, SD
7.8) published recently [49]. To help aide visualization
of clip artifact volume in relation to brain size, example
artifact volume reconstructions from the range of MR
sequences are shown in relation to patient cortical sur-
face models in Figure 2.
The ability to reconstruct nearby white matter fiber
pathways as a function of distance from the artifact bor-
der was examined in both patients. The artifact mask
delineated on the diffusion-weighted sequence was
expanded by 3D morphological dilation incrementally in
2 mm steps (Figure 3) and the volume of the white mat-
ter tracts intersecting the dilated mask was found to
increase markedly from the border, from 592 micro
liters within 2 mm of the artifact border to 2752 micro
liters within 6 mm of the border for Patient A with the
7 mm clip, and from 1348 to 4556 in Patient B with the
larger 11 mm clip. After just one increment of dilation,
pathways of the uncinate fasciculus (connecting anterior
temporal and ventral frontal lobe) and pathways of the
inferior fronto-occipital fasciculus, connecting parieto-
occipital and ventral frontal lobe [57-59], were visible in
the data of both patients (Figure 3).
Discussion
Widespread application of advanced imaging techniques
to investigate changes in brain structure, function, and
connectivity following SAH is presently slowed by the
fact that interpretation of the images obtained from
patients with implanted aneurysm clips is complicated
by the presence of an artifact in and around the clip.
The spatial extent of the artifact with respect to clip size
and type of MR sequence has not been previously
d e s c r i b e df r o mi m a g e sc o l lected from aSAH patients in
vivo. The main objective in conducting this study was to
describe the extent of image artifact produced by
implanted titanium aneurysm clips in aSAH patients
across a set of advanced MR sequences necessary to
quantify structural, functional, and connectivity patterns.
A secondary objective was to describe using DW-MRI
tractography methods how well white matter connec-
tional patterns could be reconstructed around the clip
artifact. This second objective is critical, we believe, for
beginning to understanding how well modern neuroima-
ging approaches to studying white matter can be applied
in SAH patients who have implanted aneurysm clips.
We focused on just two subarachnoid hemorrhage
patients with similar clinical characteristics, including
surgical approach, aneurysm location, Fisher’sS A H
grade [21], global distribution of subarachnoid blood,
and implanted clip size and orientation. We acknowl-
edge several limitations of this approach. First, the clini-
cal characteristic of these patients were not matched
exactly. Second, the small number of patients studied
does not allow generalization of the findings to the
entire population of aSAH patients who are treated neu-
rosurgically with clips. We cannot predict for certain
based on the findings presented here how artifact will
manifest in patients with clips placed on, for example,
the middle cerebral or basilar arteries. However, the two
patients imaged in this study had clips placed after rup-
ture of ACOM and ACA. Estimates based on large sam-
ple studies of western [60] and eastern [61,62] patient
populations indicate that these locations account for
between 29 to 38 percent of total intracranial aneurysm
ruptures. This suggests that, despite the limited scope of
our study, our findings may be generalizable to a size-
able subset of the population with titanium clips placed
at these locations. Finally, we studied patients implanted
only with straight titanium alloy clips. Patients with
Table 2 Artifact Measurements as a Function of MR Sequence
Sequence Artifact Volume
mm
3
% Of Brain Volume Artifact Length
mm
Artifact/Clip Length Ratio
Patient A T1 1038 (366) 0.45 (0.16) 25.31 (0.09) 3.61
(7 mm clip) T2 484 (185) 0.21 (0.08) 20.28 (1.80) 2.89
EPI 7366 (4767) 3.21 (2.08) 45.91 (4.72) 6.55
DW 3792 (168) 1.65 (0.07) 36.62 (2.39) 5.23
Patient B T1 2223 (428) 0.92 (0.18) 34.52 (1.19) 3.18
(11 mm clip) T2 1093 (101) 0.45 (0.04) 31.05 (0.21) 2.82
EPI 9557 (2728) 3.94 (1.13) 52.33 (4.41) 4.75
DW 6897 (2644) 2.85 (1.09) 42.97 (0.36) 3.90
The mean of the two raters’ estimates is listed with standard deviation in parentheses.
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larger artifact relative to a straight clip of same size and
weight. Furthermore, more SAH blood distribution
around the clip, more aggressive surgical manipulation
of surrounding tissue and more complex clip configura-
tion would likely increase artifact size relative to the
estimates presented here. In our limited study, two
patients studied were scanned at 3 tesla, and high
Figure 1 Appearance of Aneurysm Clip Artifact on Different Aligned MRI Sequences.A x i a ls l i c e st a k e ni nt h es a m ei m a g i n gp l a n ef o r
Patient A are displayed in the axial plane (radiological convention) with the crosshair placed in the center of the clip artifact.
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Page 6 of 11Figure 2 Example Clip Artifact Volume Reconstructions in Relation to Cortical Surface Models. Basal and mid-sagittal views of each
patient’s cortical surface model are shown shaded by curvature (top row) and as a point cloud (second row). Superimposed on the point could
displays to aide artifact visualization are the reconstructed clip artifact volumes colored according to MR sequence in descending order by clip
volume as percentage of brain volume (T2 = green, T1 = yellow, DWI = blue, EPI = red). These artifact volumes are 0.27%, 0.56%, 1.70%, and
4.67% respectively for Patient A (two columns on left), and 0.48%, 1.04%, 3.62%, and 4.74% respectively for Patient B (two columns on right).
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and DW-MRI sequences were acquired. The image
volumes were aligned to the native image space of the
high resolution T1 anatomical scan, and experienced
raters used semi-automated tracing methods to delineate
the image artifact around the aneurysm clip on each set
of image volumes. For each sequence, a 3D mask of the
artifact was produced. Mask volumes were compared
across sequences and between raters. Inter-rater reliabil-
ity was highly significant, indicating that the extent of
the image artifact was reproducible across sequences.
Most importantly, we found evidence to reject our initial
null hypothesis that the spatial extent of the image arti-
fact is the same across 3T MR acquisition sequences.
Our main result is that the size of the clip artifact varies
considerably; it is smallest in volume on the structural
scans and largest on the echo-planar BOLD-fMRI scans,
with the artifact on the DW-MRI sequence falling in
between.
The result from our second objective is that we were
surprised to learn that it is possible to reconstruct white
matter pathways very close to the artifact border using
DW-MRI data. For the two patients studied here, path-
ways comprising uncinate and inferior fronto-occipital
Figure 3 White Matter Tractography Reconstruction Ability Increases as a Function of Distance from Artifact Border. The artifact masks
derived from the diffusion-weighted image volume were dilated in 2 mm increments, and the volume of white matter tracts that intersected
any component of the dilated mask was computed. Components of the uncinate fasciculus (loop from temporal to ventral frontal) and inferior
fronto-occipital fasciculus (occipital to temporal) in both patients’ left hemisphere can be resolved within 2 mm of the artifact border by visual
inspection of the orange tractography pathways. Both views are sagittal left hemisphere where A, P, S, and I indicate anterior, posterior, superior
and inferior directions.
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artifact border. After applying a three dimensional arti-
fact mask generation method, we also provide multiple
objective measures, including an artifact/clip-length
ratio and artifact volume/brain tissue volume ratio that
can be used to guide neuroimaging researchers in esti-
mating the size of the artifact if clip characteristics like
length are known.
In hindsight, it is not too surprising that the clip arti-
fact differs considerably in size given that the sequences
required to measure structural, functional, and diffusion-
weighted connectivity information differ according to
radiofrequency pulse design, gradient readout times, and
spatial resolution. It is necessary that these parameters
differ in order for scanners to be capable of measuring
different MR signal characteristics, and it is important to
know how clip artifact size will differ as a function of
type of imaging sequence. In this study, we made no
attempt to adjust parameters in individual patients to
minimize artifact. This was a deliberate choice made to
minimize signal variance as a function of acquisition
parameters so that within-group (SAH) analyses and
between-group (SAH vs. matched control) can be con-
ducted in future larger-sample studies. For functional
imaging, there is a necessary tradeoff between high spa-
tial and temporal resolution when acquiring fMRI-BOLD
sequences. In our echo-planar fMRI sequence, we used a
2 second repetition time, meaning that hemodynamic
activity throughout 34 slices representing the entire
volume of the brain is captured every two seconds. This
acquisition speed is common for task-evoked and rest
state designs. Fast fMRI acquisitions require larger voxel
s i z e so f~3m mi no r d e rt oi m a g em o s to ft h eb r a i n .
Advances in head coil design, including the number of
channels to record the signal, will in the future allow
acquisition of higher spatial resolution scans in a shorter
time, but the spatial-temporal tradeoff will remain.
Artifact size in the fMRI-BOLD sequence acquired here
is also significantly magnified by a susceptibility artifact at
the base of the brain, near where many aneurysm clips are
likely to be placed. This well-known dropout of signal due
to a large static magnetic field inhomogeneity that occurs
near air/brain interfaces is also present in echo-planar
acquisitions in healthy controls. The interaction between
clip location and signal dropout due to the brain tissue/air
cavity susceptibility complicated delineation of the clip arti-
fact because both artifacts appeared as low intensity
regions and overlapped to some extent. However, the tis-
sue-air artifact extends outside the border of the brain, so
by constraining our artifact delineation to within-brain bor-
ders as defined by the high-resolution anatomical images
we were able to minimize this error to some extent.
Outside the boundary of our artifact masks, imaging
signal integrity recovers quickly. This was demonstrated
by reconstructing diffusion tensor tractography fiber
pathways as the artifact mask volumes were parametri-
cally dilated in three dimensions. As we used standard
diffusion tensor imaging methods here with relatively
few gradient orientations, future investigations should
evaluate the feasibility of collecting higher direction dif-
fusion-weighted sequences in order to more accurately
reconstruct white matter pathways in SAH patients
using methods like Q-ball [63] and diffusion spectrum
techniques [64]. Nevertheless, during dilation, the mask
volume was expanded to include tissue outside the arti-
fact and the number of tractography pathways increased
rapidly as the mask was dilated at successively higher
iterations, indicating an increase in our ability to exam-
ine connectivity characteristics just a few millimeters
away from the artifact mask. This is critically important
as aSAH may involve subtle damage to brain tissue near
the rupture site. The damage may cause atrophy of
nearby gray matter, altered connectivity of nearby white
matter to other brain areas, or a combination of both.
Altered network connectivity between brain regions near
the rupture site (i.e., hippocampal complex) and regions
distal to the rupture site (i.e., ventrolateral prefrontal cor-
tex) is one hypothesis that could account for complex
deficits [4], like those of memory, mood, and decision
making, that have been reported in aSAH patients. To
adequately test this hypothesis, white matter connectivity,
for tracts thought to be important for memory like the
uncinate fasciculus (shown in Figure 3 for both patients)
must be reconstructed, and the extent of artifact due to
the aneurysm clip must be quantifiable and reproducible
in order to know in which areas connectivity information
is reliable. The results presented here show how this may
be achieved through construction of a spatial confidence
boundary of signal integrity, represented numerically by
an artifact mask volume. These volumes should be con-
structed from the MR imaging data obtained from each
aSAH patient. Across patients, the spatial extent of these
artifact masks may be considered in a group analysis of
the imaging data. Using this approach, it would be possi-
ble to quantify the degree of uncertainty across patients
about whether signal in a particular region of the brain is
completely or partially affected by clip artifact. Impor-
tantly, this method is also generalizable to other methods
of assessing connectivity, like functional connectivity
computed from rest-state fMRI [65].
Conclusions
In summary, we show that artifact due to the presence
of titanium clips differs across a range of advanced
high-field (3 tesla) MR imaging sequences in aneurysmal
subarachnoid hemorrhage patients. This artifact is easily
quantifiable and 3D volumes of confidence can be pro-
duced outside of which the MR signal for measuring
Khursheed et al. BMC Medical Imaging 2011, 11:19
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Page 9 of 11structure, function, and diffusion-weighted connectivity
information may be obtained. We also show that DW-
MRI tractography can reveal white matter pathways in
close proximity to the artifact borders. These results
have important methodological implications for studying
brain changes with advanced neuroimaging tools in
patients who recover from subarachnoid hemorrhage
after neurosurgical treatment.
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